US Medicare Agency Ends New Technology Add-On Payments For Some Devices, But May Grant It For Others In 2021
The US Medicare agency will end three new technology add-on payments for devices in 2021 but continue payments for a T2 bacteria panel, and is considering the funding for other assays and devices next year.
You may also be interested in...
Beneficiaries in nursing homes and in rural areas will benefit from a telehealth expansion in the final CMS physician fee schedule rule.
A joint report by the US Government Accountability Office and the National Academy of Sciences slams the FDA for dawdling on final software as a medical device rules.
The US Medicare agency is letting ambulatory surgical centers and patient homes be reimbursed as in-patient hospitals for patient care purposes during the pandemic.